Pages that link to "Q37050199"

The following pages link to Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus (Q37050199):

Displaying 49 items.

• Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis (Q26766641) (← links)
• Esophageal cancer: Recent advances in screening, targeted therapy, and management (Q26865552) (← links)
• Upper gastrointestinal microbiota and digestive diseases (Q27002380) (← links)
• Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors (Q28076178) (← links)
• The tumor microenvironment in esophageal cancer (Q28077074) (← links)
• Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma (Q33618507) (← links)
• Microbiome in reflux disorders and esophageal adenocarcinoma (Q33997813) (← links)
• Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling (Q34585721) (← links)
• The impact of proton pump inhibitors on the human gastrointestinal microbiome (Q34625008) (← links)
• Shrinkage of the human core microbiome and a proposal for launching microbiome biobanks. (Q35193531) (← links)
• Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype (Q35234836) (← links)
• Cancer and the microbiome: potential applications as new tumor biomarker (Q35508820) (← links)
• Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model (Q35599452) (← links)
• Esophageal microbiome in eosinophilic esophagitis. (Q35644767) (← links)
• Significance of paneth cell metaplasia in Barrett esophagus: a morphologic and clinicopathologic study (Q35856606) (← links)
• Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma (Q35954977) (← links)
• Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer (Q36475989) (← links)
• The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease (Q36751990) (← links)
• Diet and upper gastrointestinal cancers: in search of dark matter (Q37195141) (← links)
• Gastrointestinal malignancy and the microbiome. (Q37716976) (← links)
• Toll-like receptors in esophageal cancer. (Q38213392) (← links)
• The esophageal microbiota in health and disease (Q38896455) (← links)
• Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression (Q39108713) (← links)
• Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma (Q40537150) (← links)
• The effect of n-3/n-6 polyunsaturated fatty acids on acute reflux esophagitis in rats (Q41326403) (← links)
• Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. (Q42448630) (← links)
• Infection and esophageal cancer (Q46832472) (← links)
• Emerging Insights into the Esophageal Microbiome (Q47723798) (← links)
• Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea (Q48000023) (← links)
• Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. (Q52312388) (← links)
• Human Gut Microbiota and Gastrointestinal Cancer. (Q52374120) (← links)
• Barrett's esophagus is associated with a distinct oral microbiome. (Q52680706) (← links)
• Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications. (Q55243343) (← links)
• The Esophageal Microbiome in Health and Disease (Q56334694) (← links)
• Signatures within the esophageal microbiome are associated with host genetics, age, and disease (Q60044490) (← links)
• Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma (Q64266070) (← links)
• Campylobacter Concisus and Its Effect on the Expression of CDX1 and COX2 (Q64896827) (← links)
• Toll-like receptor 9 expression in the natural history of Barrett mucosa (Q87046722) (← links)
• Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma (Q89514240) (← links)
• Do Sex Hormones Underlie Sex Differences in Cancer Incidence? Testing the Intuitive in Esophageal Adenocarcinoma (Q89547313) (← links)
• Microbiome and Breast Cancer: New Role for an Ancient Population (Q89967114) (← links)
• Improvement in Gastroesophageal Reflux Symptoms From a Food-grade Maltosyl-isomaltooligosaccharide Soluble Fiber Supplement: A Case Series (Q91678324) (← links)
• Destruction of the Dorsal Motor Nucleus of the Vagus Aggravates Inflammation and Injury from Acid-Induced Acute Esophagitis in a Rat Model (Q91692521) (← links)
• The Salivary Microbiome Is Altered in Children With Eosinophilic Esophagitis and Correlates With Disease Activity (Q92155997) (← links)
• Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma (Q92991997) (← links)
• Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified (Q93001645) (← links)
• Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma (Q94539008) (← links)
• Linking gut microbiota with the human diseases (Q94672157) (← links)
• Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls (Q99587557) (← links)